Universal Health Services (UHS) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
Werte in diesem Artikel
For the quarter ended December 2024, Universal Health Services (UHS) reported revenue of $4.11 billion, up 11.1% over the same period last year. EPS came in at $4.92, compared to $3.13 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $3.99 billion, representing a surprise of +2.99%. The company delivered an EPS surprise of +17.42%, with the consensus EPS estimate being $4.19.While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.Here is how Universal Health Services performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts: Net Revenues- Behavioral health services: $1.79 billion versus $1.74 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +11% change. Net Revenues- Acute care hospital services: $2.32 billion compared to the $2.26 billion average estimate based on three analysts. The reported number represents a change of +11.1% year over year. Operating Income- Behavioral Health Care Services: $361.04 million versus the two-analyst average estimate of $329.70 million. Operating Income- Acute Care Hospital Services: $218.84 million versus $198.43 million estimated by two analysts on average. View all Key Company Metrics for Universal Health Services here>>>Shares of Universal Health Services have returned +0.2% over the past month versus the Zacks S&P 500 composite's -2.3% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.Zacks' Research Chief Names "Stock Most Likely to Double"Our team of experts has just released the 5 stocks with the greatest probability of gaining +100% or more in the coming months. Of those 5, Director of Research Sheraz Mian highlights the one stock set to climb highest.This top pick is among the most innovative financial firms. With a fast-growing customer base (already 50+ million) and a diverse set of cutting edge solutions, this stock is poised for big gains. Of course, all our elite picks aren’t winners but this one could far surpass earlier Zacks’ Stocks Set to Double like Nano-X Imaging which shot up +129.6% in little more than 9 months.Free: See Our Top Stock And 4 Runners UpWant the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Universal Health Services, Inc. (UHS): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Q4
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Q4
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Universal Health Services Inc.
Analysen zu Universal Health Services Inc.
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
03.01.2019 | Universal Health Services Buy | Deutsche Bank AG | |
20.10.2017 | Universal Health Services Outperform | BMO Capital Markets | |
27.04.2017 | Universal Health Services Outperform | RBC Capital Markets | |
05.04.2017 | Universal Health Services Buy | Deutsche Bank AG | |
27.03.2017 | Universal Health Services Buy | Mizuho |
Datum | Rating | Analyst | |
---|---|---|---|
27.02.2017 | Universal Health Services Neutral | Mizuho | |
09.11.2016 | Universal Health Services Neutral | Mizuho | |
21.04.2016 | Universal Health Services Hold | Standpoint Research | |
29.10.2015 | Universal Health Services Equal Weight | Barclays Capital | |
03.08.2015 | Universal Health Services Equal Weight | Barclays Capital |
Datum | Rating | Analyst | |
---|---|---|---|
20.02.2007 | Universal Health underperform | Bear Stearns | |
31.08.2005 | Update Universal Health Services Inc.: Underperfor | Goldman Sachs | |
31.08.2005 | Universal Health underperform | Goldman Sachs | |
24.01.2005 | Update Universal Health Services Inc.: Reduce | UBS |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Universal Health Services Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen